Cited by 468HIV Research and TreatmentVirus-based gene therapy researchGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation

Open access

Jordan, Albert, Defechereux, Patricia, Verdin, Eric·2001·The EMBO Journal

DOI 10.1093/emboj/20.7.1726PMC PMC145503

Open this paper in CoChat — free account Open PDF

Abstract

Because of the heterogeneity of chromatin, the site of integration of human immunodeficiency virus (HIV) in the genome could have dramatic effects on its transcriptional activity. We have used an HIV-1-derived retroviral vector, in which the green fluorescent protein is under the control of the HIV promoter, to generate by infection 34 Jurkat clonal cell lines each containing a single integration of the HIV-1 vector. In the absence of Tat, a 75-fold difference in expression level between the highest and lowest expressing clones was observed. Basal promoter activity was low in 80% of the clones and moderate to high in the remaining 20% of clones. We found that differences in expression levels are due to the integration site and are not controlled by DNA methylation or histone acetylation. Tat activated transcription in each clone, and an inverse correlation was observed between basal transcriptional activity and inducibility by Tat. These observations demonstrate that the chromatin environment influences basal HIV gene expression and that the HIV Tat protein activates transcription independently of the chromatin environment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/emboj/20.7.1726

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Dissecting the regulatory circuitry of a eukaryotic genome
Holstege, F. C. P., Jennings, E. G., Wyrick, J. J., Lee, T. I., Hengartner, C. J., Green, M. R., Golub, T. R., Lander, E. S., & Young, R. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81641-4 · Cited by 1,670
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
Ory, D., Neugeboren, B. I., & Mulligan, R. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11400 · Cited by 926
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product
Kao, S.-Y., Calman, A. F., Luciw, P. A., & Peterlin, B. M. (1987) · Nature · doi:10.1038/330489a0 · Cited by 908
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
Zennou, V., Petit, C., Guétard, D., Nerhbass, U., Montagnier, L., & Charneau, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80828-4 · Cited by 864
Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition
Miller, M. D., Farnet, C. M., & Bushman, F. D. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5382-5390.1997 · Cited by 620
Transcriptional activation and chromatin remodeling of the HIV‐1 promoter in response to histone acetylation.
Lint, C. M. V., Emiliani, S., Ott, M., & Verdin, E. M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00449.x · Cited by 579
Self-citation
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitroPreprint
Mancebo, H. S. Y., Lee, G., Flygare, J. A., Tomassini, J. E., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D. J., Price, D. H., et al. (1997) · Genes & Development · doi:10.1101/gad.11.20.2633 · Cited by 546
Binding and Stimulation of HIV-1 Integrase by a Human Homolog of Yeast Transcription Factor SNF5
Kalpana, G. V., Marmon, S., Wang, W., Crabtree, G. R., & Goff, S. P. (1994) · Science · doi:10.1126/science.7801128 · Cited by 530
Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.
Verdin, E. M., Paras, P., & Lint, C. M. V. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05994.x · Cited by 520
Self-citation

Show all 48 references

Sorted by citations

Items 101–200 of 468

Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation
Márquez, N., Calzado, M. A., Sánchez‐Duffhues, G., Pérez, M., Minassi, A., Pagani, A., Appendino, G., Díaz, L., Muñoz‐Fernández, M. Á., & Muñóz, E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.12.004 · Cited by 80
The chromatin landscape at the HIV-1 provirus integration site determines viral expression
Vansant, G., Chen, H., Zorita, E. V., Trejbalová, K., Miklík, D., Filion, G. J. P., & Debyser, Z. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa536 · Cited by 79
Context-aware synthetic biology by controller design: Engineering the mammalian cell
Shakiba, N., Jones, R. D., Weiss, R., & Vecchio, D. D. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.011 · Cited by 78
Retroviral integration site selection
Desfarges, S., & Ciuffi, A. (2010) · Viruses · doi:10.3390/v2010111 · Cited by 78
Postintegrative Gene Silencing within the Sleeping Beauty Transposition System
Garrison, B. S., Yant, S. R., Mikkelsen, J. G., & Kay, M. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00498-07 · Cited by 78
Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice
Waddington, S. N., Mitrophanous, K. A., Ellard, F. M., Buckley, S. M. K., Nivsarkar, M. S., Lawrence, L., Cook, H. T., Al-Allaf, F. A., Bigger, B., Kingsman, S. M., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301991 · Cited by 78
HIV-1 Nef Mimics an Integrin Receptor Signal that Recruits the Polycomb Group Protein Eed to the Plasma Membrane
Witte, A. V., Laffert, B., Rosorius, O., Lischka, P., Blume, K., Galler, G. R., Stilper, A., Willbold, D., D’Aloja, P., Sixt, M., et al. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00004-8 · Cited by 79
HIV integration sites in latently infected cell lines: evidence of ongoing replication
Symons, J., Chopra, A., Malatinková, E., Spiegelaere, W. D., Leary, S., Cooper, D., Abana, C. O., Rhodes, A., Rezaei, S. D., Vandekerckhove, L., et al. (2017) · Retrovirology · doi:10.1186/s12977-016-0325-2 · Cited by 83
Transcription: Insights From the HIV-1 Promoter
Ne, E., Palstra, R.-J. T. S., & Mahmoudi, T. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.07.011 · Cited by 89
Effect of Ku80 Depletion on the Preintegrative Steps of HIV-1 Replication in Human Cells
Jeanson, L., Subra, F., Vaganay, S., Hervy, M., Marangoni, E., Bourhis, J., & Mouscadet, J. F. (2002) · Virology · doi:10.1006/viro.2002.1515 · Cited by 77
Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
Li, C., Mousseau, G., & Valente, S. T. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0267-8 · Cited by 74
Cell Cycle Arrest in G 2 /M Promotes Early Steps of Infection by Human Immunodeficiency Virus
Gröschel, B., & Bushman, F. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5695-5704.2005 · Cited by 76
Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+T cells
Sung, T.-L., & Rice, A. P. (2006) · Retrovirology · doi:10.1186/1742-4690-3-66 · Cited by 74
Transcriptional competence of the integrated HIV‐1 provirus at the nuclear periphery
Dieudonné, M., Maiuri, P., Biancotto, C., Knezevich, A., Kula, A., Lušić, M., & Marcello, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.141 · Cited by 77
Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selection
Demeulemeester, J., De Rijck, J., Gijsbers, R., & Debyser, Z. (2015) · BioEssays · doi:10.1002/bies.201500051 · Cited by 71
Human Immunodeficiency Virus (HIV) Latency: The Major Hurdle in HIV Eradication
Tyagi, M., & Bukrinsky, M. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00194 · Cited by 73
In vitro modeling of the HIV-macrophage reservoir
Brown, A. M., Zhang, H., Lopez, P., Pardo, C. A., & Gartner, S. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0206126 · Cited by 72
Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies
Demonté, D., Quivy, V., Colette, Y., & Lint, C. M. V. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.040 · Cited by 70
Human retroviruses after 20 years: a perspective from the past and prospects for their future control
Gallo, R. C. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18520.x · Cited by 69
The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb
Lu, P., Qu, X., Shen, Y., Jiang, Z., Wang, P., Zeng, H., Ji, H., Deng, J., Yang, X., Li, X., et al. (2016) · Scientific Reports · doi:10.1038/srep24100 · Cited by 66
HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes
Redel, L., Douce, V. L., Cherrier, T., Marban, C., Janossy, A., Aunis, D., Lint, C. M. V., Rohr, O., & Schwartz, C. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0409264 · Cited by 74
Computational Design of Antiviral RNA Interference Strategies That Resist Human Immunodeficiency Virus Escape
Leonard, J. N., & Schaffer, D. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1645-1654.2005 · Cited by 66
Development of 5‘ LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals
Trejbalová, K., Kovářová, D., Blažková, J., Machala, L., Jilich, D., Weber, J., Kučerová, D., Vencálek, O., Hirsch, I., & Hejnar, J. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0185-6 · Cited by 67
Lost in Transcription: Molecular Mechanisms that Control HIV Latency
Taube, R., & Peterlin, B. M. (2013) · Viruses · doi:10.3390/v5030902 · Cited by 63
Capsid-CPSF6 Interaction Is Dispensable for HIV-1 Replication in Primary Cells but Is Selected during Virus Passage In Vivo
Saito, A., Henning, M. S., Serrao, E., Dubose, B. N., Teng, S., Huang, J., Li, X., Saito, N., Roy, S. P., Siddiqui, M. A., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00019-16 · Cited by 61
Varying virulence: epigenetic control of expression noise and disease processes
Miller‐Jensen, K., Dey, S. S., Schaffer, D. V., & Arkin, A. P. (2011) · Trends in biotechnology · doi:10.1016/j.tibtech.2011.05.004 · Cited by 62
A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain
Kakizoe, Y., Nakaoka, S., Beauchemin, C. A. A., Morita, S., Mori, H., Igarashi, T., Aihara, K., Miura, T., & Iwami, S. (2015) · Scientific Reports · doi:10.1038/srep10371 · Cited by 63
Impact of Using Different Promoters and Matrix Attachment Regions on Recombinant Protein Expression Level and Stability in Stably Transfected CHO Cells
Ho, S. C. L., Mariati, Yeo, J. H. M., Fang, S. G., & Yang, Y. (2014) · Molecular Biotechnology · doi:10.1007/s12033-014-9809-2 · Cited by 62
Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS
Johansen, J. L., Rosenblad, C., Andsberg, K., Møller, A., Lundberg, C., Björlund, A., & Johansen, T. E. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301778 · Cited by 61
Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents
Margolis, D. M., & Archin, N. M. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw618 · Cited by 62
Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation
Ding, D., Qu, X., Li, L., Zhou, X., Liu, S., Lin, S., Wang, P., Liu, S., Kong, C., Wang, X., et al. (2013) · Virology · doi:10.1016/j.virol.2013.02.022 · Cited by 60
Chromatin dynamics associated with HIV-1 Tat-activated transcription
Easley, R. L., Duyne, R. V., Coley, W., Guendel, I., Dadgar, S., Kehn‐Hall, K., & Kashanchi, F. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.08.008 · Cited by 58
Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency
Telwatte, S., Morón‐López, S., Aran, D., Kim, P., Hsieh, C. L., Joshi, S. K., Montaño, M., Greene, W. C., Butte, A. J., Wong, J. K., et al. (2019) · Retrovirology · doi:10.1186/s12977-019-0494-x · Cited by 60
Toolbox for retrovectorologists
Pagès, J., & Bru, T. (2004) · Journal of Gene Medicine · doi:10.1002/jgm.498 · Cited by 60
Transcription of HIV: Tat and Cellular Chromatin
Gatignol, A. (2007) · Advances in pharmacology · doi:10.1016/s1054-3589(07)55004-0 · Cited by 70
Mechanisms of HIV Transcriptional Regulation and Their Contribution to Latency
Lester, G. M. S., & Henderson, A. J. (2012) · Molecular Biology International · doi:10.1155/2012/614120 · Cited by 55
Cardiovascular gene therapy for myocardial infarction
Scimia, M. C., Gumpert, A. M., & Koch, W. J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.866085 · Cited by 56
A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other “Shock” Drugs
Abner, E., Stoszko, M., Zeng, L., Chen, H., Izquierdo‐Bouldstridge, A., Konuma, T., Zorita, E. V., Fanunza, E., Zhang, Q., Mahmoudi, T., et al. (2018) · Journal of Virology · doi:10.1128/jvi.02056-17 · Cited by 54
Self-citation
Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency Reversal
Marian, C., Stoszko, M., Wang, L., Leighty, M. W., Crignis, E. D., Maschinot, C. A., Gatchalian, J., Carter, B. C., Chowdhury, B., Hargreaves, D. C., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.08.004 · Cited by 56
The Molecular Biology of HIV Latency
Khoury, G., Darcis, G., Lee, M. Y.-H., Bouchat, S., Driessche, B. V., Purcell, D. F. J., & Lint, C. M. V. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0484-2_8 · Cited by 55
Transcriptional Suppression of In Vitro-Integrated Human Immunodeficiency Virus Type 1 Does Not Correlate with Proviral DNA Methylation
Pion, M., Jordan, A., Biancotto, A., Dequiedt, F., Gondois‐Rey, F., Rondeau, S., Vigne, R., Hejnar, J., Verdin, E. M., & Hirsch, I. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4025-4032.2003 · Cited by 56
Self-citation
TASOR epigenetic repressor cooperates with a CNOT1 RNA degradation pathway to repress HIV
Matkovic, R., Morel, M., Lanciano, S., Larrous, P., Martin, B., Bejjani, F., Vauthier, V., Hansen, M. M. K., Emiliani, S., Cristofari, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27650-5 · Cited by 61
Human Immunodeficiency Virus Integration Efficiency and Site Selection in Quiescent CD4 + T Cells
Vatakis, D. N., Kim, S., Kim, N., Chow, S. A., & Zack, J. A. (2009) · Journal of Virology · doi:10.1128/jvi.00356-09 · Cited by 52
HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay
Sunshine, S., Kirchner, R., Amr, S. S., Mansur, L., Shakhbatyan, R., Kim, M., Bosque, A., Siliciano, R. F., Planelles, V., Hofmann, O., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01617-15 · Cited by 54
Efficient In Vivo Targeting of Epidermal Stem Cells by Early Gestational Intraamniotic Injection of Lentiviral Vector Driven by the Keratin 5 Promoter
Endo, M., Zoltick, P. W., Peranteau, W. H., Radu, A. P., Muvarak, N. E., Ito, M., Yang, Z., Cotsarelis, G., & Flake, A. W. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300332 · Cited by 52
Rev-dependent lentiviral expression vector
Wu, Y., Beddall, M. H., & Marsh, J. W. (2007) · Retrovirology · doi:10.1186/1742-4690-4-12 · Cited by 52
Inhibition of Early Steps of HIV-1 Replication by SNF5/Ini1
Maroun, M., Delelis, O., Coadou, G., Bader, T., Ségéral, E., Mbemba, G., Petit, C., Sonigo, P., Rain, J., Mouscadet, J. F., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604849200 · Cited by 52
HIV-1 latency in actively dividing human T cell lines
Jeeninga, R. E., Westerhout, E. M., van Gerven, M. L., & Berkhout, B. (2008) · Retrovirology · doi:10.1186/1742-4690-5-37 · Cited by 52
HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell
Boullé, M., Müller, T. G., Dähling, S., Ganga, Y., Jackson, L., Mahamed, D., Lance, O., Lustig, G., Neher, R. A., & Sigal, A. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005964 · Cited by 52
BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
Lu, P., Shen, Y., Yang, H. B., Wang, Y., Jiang, Z., Yang, X., Zhong, Y., Pan, H., Xu, J., Lu, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16816-1 · Cited by 51
Genomic Sites of Human Immunodeficiency Virus Type 2 (HIV-2) Integration: Similarities to HIV-1 In Vitro and Possible Differences In Vivo
MacNeil, A., Sankalé, J.-L., Meloni, S., Sarr, A. D., Mboup, S., & Kanki, P. J. (2006) · Journal of Virology · doi:10.1128/jvi.00604-06 · Cited by 51
Induction of chromosomally integrated HIV-1 LTR requires RBF-2 (USF/TFII-I) and RAS/MAPK signaling
Malcolm, T., Chen, J., Chang, C., & Sadowski, I. (2007) · Virus Genes · doi:10.1007/s11262-007-0109-9 · Cited by 49
The Integrase Cofactor LEDGF/p75 Associates with Iws1 and Spt6 for Postintegration Silencing of HIV-1 Gene Expression in Latently Infected Cells
Gérard, A., Ségéral, E., Naughtin, M., Abdouni, A., Muylder, B. C.-D., Cheynier, R., Rain, J., & Emiliani, S. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2014.12.002 · Cited by 61
Identification, structural modification, and dichotomous effects on human immunodeficiency virus type 1 (HIV-1) replication of ingenane esters from Euphorbia kansui
Liu, Q., Li, W., Huang, L., Asada, Y., Morris-Natschke, S. L., Chen, C., Lee, K., & Koike, K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.020 · Cited by 49
The Regulation of HIV-1 Gene Expression: The Emerging Role of Chromatin
He, G., Ylisastigui, L., & Margolis, D. M. (2002) · DNA and Cell Biology · doi:10.1089/104454902760599672 · Cited by 49
HIV-1 Proviral Transcription and Latency in the New Era
Shukla, A., Ramirez, N.-G. P., & D’Orso, I. (2020) · Viruses · doi:10.3390/v12050555 · Cited by 52
Nuclear organization and the control of HIV-1 transcription
Marcello, A., Lušić, M., Pegoraro, G., Pellegrini, V., Beltram, F., & Giacca, M. (2003) · Gene · doi:10.1016/j.gene.2003.10.018 · Cited by 51
Intasome architecture and chromatin density modulate retroviral integration into nucleosome
Benleulmi, M. S., Matysiak, J., Henriquez, D. R., Vaillant, C., Lesbats, P., Calmels, C., Naughtin, M., Leon, O., Skalka, A. M., Ruff, M., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0145-9 · Cited by 47
Therapy for Latent HIV-1 Infection: The Role of Histone Deacetylase Inhibitors
McManamy, M. E. M., Hakre, S., Verdin, E. M., & Margolis, D. M. (2013) · Antiviral chemistry & chemotherapy · doi:10.3851/imp2551 · Cited by 47
Self-citation
FoxP3 Enhances HIV-1 Gene Expression by Modulating NFκB Occupancy at the Long Terminal Repeat in Human T Cells
Holmes, D., Knudsen, G. T., Mackey-Cushman, S., & Su, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702051200 · Cited by 46
Gene transcription in HIV infection
Wu, Y., & Marsh, J. W. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00187-4 · Cited by 47
HIV-1 Tat Interactions with p300 and PCAF Transcriptional Coactivators Inhibit Histone Acetylation and Neurotrophin Signaling through CREB
Mauldin, K., Sharma, A., Awasthi, S., Matlock, E. F., Rogers, L., Lint, C. M. V., Skiest, D. J., Burns, D. K., & Harrod, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408643200 · Cited by 46
NF-κB-Chromatin Interactions Drive Diverse Phenotypes by Modulating Transcriptional Noise
Wong, V. C., Bass, V. L., Bullock, M. E., Chavali, A. K., Lee, R., Mothes, W., Gaudet, S., & Miller‐Jensen, K. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.080 · Cited by 48
Host factors regulating post-integration latency of HIV
Williams, S. A., & Greene, W. C. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.02.006 · Cited by 46
CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies
Gray, L. R., Cowley, D., Welsh, C., Lu, H. K., Brew, B. J., Lewin, S. R., Wesselingh, S. L., Gorry, P. R., & Churchill, M. J. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.111 · Cited by 43
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
Stoszko, M., Crignis, E. D., Rokx, C., Khalid, M. M., Lungu, C., Palstra, R.-J. T. S., Kan, T. W., Boucher, C. A., Verbon, A., Dykhuizen, E. C., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.047 · Cited by 45
Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1
Martínez‐Bonet, M., Clemente, M. I., Serramía, M. J., Muñóz, E., Moreno, S., & Muñoz‐Fernández, M. Á. (2015) · Scientific Reports · doi:10.1038/srep16445 · Cited by 43
Functional proteomic atlas of HIV infection in primary human CD4+ T cells
Naamati, A., Williamson, J. C., Greenwood, E. J. D., Marelli, S., Lehner, P. J., & Matheson, N. J. (2019) · eLife · doi:10.7554/elife.41431 · Cited by 44
Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals
Wonderlich, E. R., Subramanian, K., Cox, B. D., Wiegand, A. P., Lackman-Smith, C., Bale, M. J., Stone, M., Hoh, R., Kearney, M. F., Maldarelli, F. M., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008074 · Cited by 43
Molecular mechanisms of HIV-1 proviral latency
Bisgrove, D. A., Lewinski, M. K., Bushman, F. D., & Verdin, E. M. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.5.805 · Cited by 42
Self-citation
Integration site selection by retroviruses.
Cereseto, A., & Giacca, M. (2004) · PubMed · Cited by 43
Mechanisms of HIV transcriptional regulation by drugs of abuse
Tyagi, M., Bukrinsky, M., & L. Simon, G. (2016) · Current HIV Research · doi:10.2174/1570162x14666160324124736 · Cited by 42
Mechanisms That Regulate Silencing of Gene Expression from Retroviral Vectors
Swindle, C. S., & Klug, C. A. (2002) · Stem Cells and Development · doi:10.1089/15258160260090915 · Cited by 41
Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation
Albert, B. J., Niu, A., Ramani, R., Marshall, G. R., Wender, P. A., Williams, R. M., Ratner, L., Barnes, A. B., & Kyei, G. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-07814-4 · Cited by 42
Preferential integration of human immunodeficiency virus type 1 into genes, cytogenetic R bands and GC‐rich DNA regions: insight from the human genome sequence
Elleder, D., Pavlı́ček, A., Pačes, J., & Hejnar, J. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02612-1 · Cited by 41
Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system
Quivy, V., & Lint, C. M. V. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01152-8 · Cited by 40
The BAF complex and HIV latency
Mahmoudi, T. (2012) · Transcription · doi:10.4161/trns.20541 · Cited by 41
Insight in HIV Integration Site Selection Provides a Block-and-Lock Strategy for a Functional Cure of HIV Infection
Debyser, Z., Vansant, G., Bruggemans, A., Janssens, J., & Christ, F. (2018) · Viruses · doi:10.3390/v11010012 · Cited by 41
Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4 + T cell activation and HIV-1 latency reversal
Cao, S., Slack, S. D., Levy, C., Hughes, S. M., Jiang, Y., Yogodzinski, C., Roychoudhury, P., Jerome, K. R., Schiffer, J. T., Hladik, F., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav6322 · Cited by 39
Direct non-productive HIV-1 infection in a T-cell line is driven by cellular activation state and NFκB
Dahabieh, M. S., Ooms, M., Brumme, C. J., Taylor, J. M. G., Harrigan, P. R., Simon, V. R., & Sadowski, I. (2014) · Retrovirology · doi:10.1186/1742-4690-11-17 · Cited by 41
Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency
Irwan, I. D., Bogerd, H. P., & Cullen, B. R. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01264-z · Cited by 39
Epigenetic crosstalk in chronic infection with HIV-1
Lange, U. C., Verdikt, R., Aït-Ammar, A., & Lint, C. M. V. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00783-3 · Cited by 41
PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF‐κB signaling
Yang, X., Wang, Y., Lu, P., Shen, Y., Zhao, X., Zhu, Y., Jiang, Z., Yang, H. B., Pan, H., Zhao, L., et al. (2020) · EMBO Reports · doi:10.15252/embr.201949305 · Cited by 39
Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority
Mok, H. P., Javed, S., & Lever, A. M. L. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302923 · Cited by 44
Selective Histonedeacetylase Inhibitor M344 Intervenes in HIV-1 Latency through Increasing Histone Acetylation and Activation of NF-kappaB
Ying, H., Zhang, Y., Zhou, X., Qu, X., Wang, P., Liu, S., Lu, D., & Zhu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048832 · Cited by 38
Lessons Learned from HIV Vaccine Clinical Efficacy Trials
Day, T., & Kublin, J. G. (2014) · Current HIV Research · doi:10.2174/1570162x113116660051 · Cited by 37
Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C–induced HIV latency reversal
Matsuda, K., Kobayakawa, T., Tsuchiya, K., Hattori, S.-I., Nomura, W., Gatanaga, H., Yoshimura, K., Oka, S., Endo, Y., Tamamura, H., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005798 · Cited by 36
Measurement of Human Immunodeficiency Virus Type 1 Preintegration Transcription by Using Rev-Dependent Rev-CEM Cells Reveals a Sizable Transcribing DNA Population Comparable to That from Proviral Templates
Iyer, S. R., Yu, D., Biancotto, A., Margolis, L. B., & Wu, Y. (2009) · Journal of Virology · doi:10.1128/jvi.00874-09 · Cited by 37
TFII-I and USF (RBF-2) regulate Ras/MAPK-responsive HIV-1 transcription in T cells
Sadowski, I., & Mitchell, D. A. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.011 · Cited by 34
New insights in the role of nucleoporins: A bridge leading to concerted steps from HIV-1 nuclear entry until integration
Nunzio, F. D. (2013) · Virus Research · doi:10.1016/j.virusres.2013.09.003 · Cited by 43
Chromatin-Associated Regulation Of Hiv-1 Transcription
Quivy, V., de Walque, S., & Lint, C. M. V. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_17 · Cited by 36
Genetic Selection for Context-Dependent Stochastic Phenotypes: Sp1 and TATA Mutations Increase Phenotypic Noise in HIV-1 Gene Expression
Miller‐Jensen, K., Skupsky, R., Shah, P. S., Arkin, A. P., & Schaffer, D. V. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003135 · Cited by 36
High-Frequency Epigenetic Repression and Silencing of Retroviruses Can Be Antagonized by Histone Deacetylase Inhibitors and Transcriptional Activators, but Uniform Reactivation in Cell Clones Is Restricted by Additional Mechanisms
Katz, R. A., Jack-Scott, E., Narezkina, A., Palagin, I. S., Boimel, P. J., Kulkosky, J., Nicolas, É., Greger, J., & Skalka, A. M. (2007) · Journal of Virology · doi:10.1128/jvi.01643-06 · Cited by 36
Chromatin, gene silencing and HIV latency
Mok, H. P., & Lever, A. M. L. (2007) · Genome biology · doi:10.1186/gb-2007-8-11-228 · Cited by 38
Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a
Armani-Tourret, M., Gao, C., Hartana, C. A., Sun, W., Carrere, L., Vela, L., Hochroth, A., Bellefroid, M., Sbrolla, A., Shea, K., et al. (2024) · Cell · doi:10.1016/j.cell.2024.01.037 · Cited by 37
In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation
Brogdon, J. M., Ziani, W., Wang, X., Veazey, R. S., & Xu, H. (2016) · Scientific Reports · doi:10.1038/srep39032 · Cited by 34
Mutations altering acetylated residues in the CTD of HIV-1 integrase cause defects in proviral transcription at early times after integration of viral DNA
Winans, S., & Goff, S. P. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1009147 · Cited by 29
Optimized Selection Marker and CHO Host Cell Combinations for Generating High Monoclonal Antibody Producing Cell Lines
Yeo, J. H. M., Ho, S. C. L., Mariati, M., Koh, E. Y. C., Tay, S. J., Woen, S., Zhang, P., & Yang, Y. (2017) · Biotechnology Journal · doi:10.1002/biot.201700175 · Cited by 36
Insights into the HIV Latency and the Role of Cytokines
Hokello, J., Sharma, A. L., Dimri, M., & Tyagi, M. (2019) · Pathogens · doi:10.3390/pathogens8030137 · Cited by 34
Bis-Anthracycline Antibiotics Inhibit Human Immunodeficiency Virus Type 1 Transcription
Kutsch, O., Levy, D. N., Bates, P. J., Decker, J. M., Kosloff, B. R., Shaw, G. M., Priebe, W., & Benveniste, E. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1652-1663.2004 · Cited by 34

Authors: Jordan, A., Defechereux, P., & Verdin, E.
Affiliations: University of California, San Francisco (US)
Corresponding author: Verdin, Eric
ORCID: Jordan, Albert
Verdin, Eric
Venue: The EMBO Journal
Publisher: Springer Science and Business Media LLC
Published: 2001-04-02
Volume: 20
Issue: 7
Pages: 1726-1738
ISSN: 0261-4189 (ISSN-L)
1460-2075
DOI: 10.1093/emboj/20.7.1726
PMC: PMC145503
OpenAlex: W1964660012
Cited by: 467
References: 48
Citations by year: 2026: 13 · 2025: 21 · 2024: 19 · 2023: 18 · 2022: 15 · 2021: 15 · 2020: 21 · 2019: 21 · 2018: 20 · 2017: 26 · 2016: 25 · 2015: 27 · 2014: 14 · 2013: 15 · 2012: 14
FWCI: 6.25
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: The EMBO Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Belgian American Educational Foundation
National Institutes of Health
National Institute of General Medical Sciences (GM51671-05A2, R01GM051671)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: Tat transactivation, basal transcription, chromatin environment, HIV-1 promoter, retroviral vectors, Jurkat cells, DNA methylation, histone acetylation, HIV gene expression
MeSH terms: Binding Sites, Cell Line, Transformed, Genetic Vectors, HeLa Cells, Humans, Hydroxamic Acids, Promoter Regions, Genetic, Tetradecanoylphorbol Acetate, Transcription, Genetic, HIV-1, Transcriptional Activation, Gene Products, tat, Genome, Human, Gene Expression Regulation, Viral, HIV Long Terminal Repeat, Virus Integration, Cyclin-Dependent Kinases, Jurkat Cells, DNA Methylation, Cyclin-Dependent Kinase 9, tat Gene Products, Human Immunodeficiency Virus, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks